MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in BMY — Bristol Myers Squibb Co
CIK 912938
Boston, MA
Position in BMY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$63,731,927
+$22,303,852 QoQ
Shares Held
1,050,815
+36.8% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 63.01584960245143.ToString("F0")%
Shared 14.075170225015821.ToString("F0")%
None 22.908980172532747.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $7,300,763,534 across 12 Drug Manufacturers - General names. BMY ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,434,302 | $3,283,880,778 | |
| 2 | PFE |
Pfizer Inc
|
56,911,830 | $1,598,084,183 | |
| 3 | ABBV |
AbbVie Inc.
|
5,610,330 | $1,220,190,668 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,281,609 | $875,467,841 | |
| 5 | BIIB |
Biogen Inc.
|
720,629 | $132,112,911 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
1,050,815 | $63,731,927 | |
| 7 | NVS |
Novartis AG
|
246,655 | $37,676,550 | |
| 8 | MRK |
Merck & Co., Inc.
|
271,829 | $32,698,308 |
All Filings in BMY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,731,927 | 1,050,815 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $41,428,075 | 768,040 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,701,762 | 82,079 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,652,048 | 78,895 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,298,284 | 37,683 | Shares | Sole | 2025-05-02 | |
| 2023-06-30 | $224,784 | 3,515 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,273,571 | 18,375 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,207,608 | 16,784 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $293,104 | 4,123 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $340,956 | 4,428 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $294,749 | 4,036 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,653,802 | 42,563 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,494,606 | 42,160 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $439,475 | 6,577 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $875,296 | 13,865 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $24,716,065 | 409,953 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $35,435,348 | 602,642 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $48,094,755 | 862,841 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||